Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

LITSLITS
10 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in MEI PHARMA INC

CITADEL ADVISORS LLC holds 357,529 shares of LITS (MEI PHARMA INC), worth $329,785 as of 2026-Q2. The position was decreased (-51.0% shares).

Current Value

$329,785

Current Shares

357,529

Total Value Change

+$327,025

Total Shares Change

+356,839

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
357,529
-51.0%
$329,7850.0%$0.92
0
2026-Q1
Decreased
730,099
-47.0%
$846,9150.0%$1.15
0
2025-Q4
Decreased
1.4M
-34.4%
$1.8M0.0%$1.38
0
2025-Q3
New
2.1M
-
$5.1M0.0%$2.54
37
2025-Q2
Exited
0
-100.0%
$00.0%$2.80
0
2025-Q1
Increased
37,146
+1.3%
$81,3500.0%$2.35
15
2024-Q4
New
36,665
-
$90,1960.0%$2.45
33
2024-Q3
Exited
0
-100.0%
$00.0%$2.90
0
2024-Q2
Increased
15,887
+2202.5%
$46,2310.0%$2.91
22
2024-Q1
New
690
-
$2,7600.0%$4.00
20

Other major holders of LITS: RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used